Eli Lilly Antibody Cuts Covid-19 Risk Up to 80% in Nursing Home Study
Source: Bloomberg By Riley Griffin Eli Lilly & Co.’s antibody therapy reduced nursing home residents’ risk of symptomatic Covid-19 by as much as 80% when used preventively in a study. The […]